Curriculum Vitae

Devon Lee Graham

May 29, 2019

General Information

University address:	Biomedical Sciences
College of Medicine
Com -Research Bldg 3300
Florida State University
Tallahassee, Florida 32306-4300
Phone: 850/645-2823

E-mail address:	devon.graham@med.fsu.edu

Professional Preparation

2007	PhD, University of Maryland Baltimore. Major: Toxicology. 

2000	BS, Allegheny College. Major: Biology. 

Unspecified Name. (2000). Analysis of the expression of the von Willebrand factor gene via single and double mutations in the Yin Yang I sites of the 51st intron. Unpublished bachelor's thesis, Allegheny College. 

Professional Experience

2015–present	Research Faculty I, MEDICINE BIOMEDICAL SCIENCES, Florida State University. 

2011–2015	Postdoctoral Research Fellow, Pharmacology, Vanderbilt University. 

2007–2011	Postdoctoral Research Fellow, Neurology, Cincinnati Children's Research Foundation. 

2007	Student Intern, Science Information Management Branch, U.S. Environmental Protection Agency. 

2003–2007	Predoctoral Fellow, DHHS/NIH/NIDA/IRP. 

2000–2003	Research Technician, Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine. 

Honors, Awards, and Prizes

Society for Neuroscience Chapter Postdoctoral Travel Award (2013). 
Travel Award, Cold Spring Harbor Laboratory's "Cellular Biology of Addiction" course (2013). 
Conference Award, Neurobehavioral Teratology Society (2011). 
Behavioral Toxicology Award, Neurobehavioral Teratology Society (2010). 
Invited Exemplary Fellow, Environmental Health Sciences Regional Showcase of Fellows (2009). 
Merck and Co., Inc., Conference Award, Neurobehavioral Teratology Society (2008). 
Women in Toxicology Student Achievement Award, Society of Toxicology (2008). 
NIH Predoctoral Intramural Research Training Award (2007). 
Toxicology Scholar Travel Grant, Society of Toxicology (2006). 
Graduate Travel Award, Society of Toxicology (2005). 
Graduate Merit Award, University of Maryland (2004). 
Presidential Scholar, Allegheny College (2000). 
Alden Scholar, Allegheny College (1999). 

Fellowship(s)

Winter Conference on Brain Research (2015).

Current Membership in Professional Organizations

Developmental Neurotoxicology Society (formerly NBTS) 
Society for Neuroscience (SfN) 

Teaching

Courses Taught

Clinical Pharmacology II (PAS5072)

Supervision of Student Research Not Related to Thesis or Dissertation

Henderson, N. (Feb 2018–present). 

Madkour, H. (Feb 2018–present). 

Murray, T. (2018). 

Trammell, T. (2015–18). 

Jackson, O. (2016–17). 

Brown, K. (2015–16). 

Campos, M. (2014–16). 

Garden, J. (2012–14). 

Khan, M. (2011). 

Sebastian, K. (2008). 

Sims, L. (2008). 

Norise, C. (2006). 

Asanbe, O. (2005). 

Johnson, M. (2004). 

Research and Original Creative Work

Publications

Refereed Journal Articles

Graham, D. L., Durai, H. H., Trammell, T. S., Mortlock, D. P., Galli, A., & Stanwood, G. D. (submitted). A novel mouse model of GLP-1 receptor expression: a look at the brain to determine cell specificity. Journal of Comparative Neurology. Manuscript submitted for publication.

Larson, J. J., Graham, D. L., Singer, L. T., Anna, B. M., Terplan, M., Davis, J. M., Martinez, J., & Bada, H. S. (submitted). A cognitive and behavioral impact on children exposed to opioids during pregnancy. Pediatrics. Manuscript submitted for publication.

Jablonski, S., Graham, D. L., Vorhees, C., & Williams, M. (2017). Effects of neonatal methamphetamine and stress on brain monoamines and corticosterone in preweanling rats. Neurotoxicity Research, 31, 269-282.

Amos-Kroohs, R., Graham, D. L., Grace, C., Braun, A., Schaefer, T., Skelton, M., Vorhees, C., & Williams, M. (2016). Developmental stress and lead (Pb): Effects of maternal separation and/or Pb on corticosterone, monoamines, and blood Pb in rats. Neurotoxicology, 54, 22-23.

Martin, M., Graham, D. L., McCarthy, D., Bhide, P., & Stanwood, G. (2016). Cocaine- induced neurodevelopmental deficits and underlying mechanisms. Birth Defects Research C: Embryo Today, 108, 147-173.

Reddy, I., Pino, J., Osses, N., Sorenson, G., Bering, T., Valle, C., Bluett, R., Erreger, K., Wortwein, G., Reyes, J., Graham, D., Stanwood, G., Hackett, T., Patel, S., Fink-Jensen, A., Torres, G., & Galli, A. (2016). Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Translational Psychiatry, 6, 809.

Frederick, A., Yano, H., Trifilieff, P., Vishwasrao, H., Biezonski, D., Meszaros, J., Sibley, D., Kellendonk, C., Sonntag, K., Graham, D. L., Colbran, R., Stanwood, G., & Javitch, J. (2015). Evidence against dopamine D1/D2 receptor heteromers. Molecular Psychiatry, 20, 1373-1385.

Graham, D. L., Buendia, M., Chapman, M., Durai, H., & Stanwood, G. (2015). Deletion of Gαq from the telencephalon alters specific neurobehavioral outcomes. Synapse, 69, 434-445.

Ross, E., Money, K., Graham, D. L., & Stanwood, G. (2015). Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology, 40, 61-87.

Sorenson, G., Reddy, I., Weikop, P., Graham, D. L., Stanwood, G., Woertwein, G., Galli, A., & Fink-Jensen, A. (2015). The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiology and Behavior, 149, 262-268.

Vorhees, C., Graham, D. L., Braun, A., Schaefer, T., Skelton, M., Richtand, N., & Williams, M. (2015). Prenatal immune challenge in rats: Prenatal immune challenge in rats: Effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine. Neurotoxicology and Teratology, 47, 54-65.

Graham, D. L., Durai, H., Garden, J., Cohen, E., Echevarria, F., & Stanwood, G. (2014). Loss of dopamine D2 receptor increases parvalbumin-positive interneurons in the anterior cingulate cortex. ACS Chemical Neuroscience, 6, 297-305.

Vorhees, C., Graham, D. L., Amos-Kroohs, R., Braun, A., Grace, C., Schaefer, T., Skelton, M., Erikson, K., Aschner, M., & Williams, M. (2014). Effects of developmental manganese, stress, and the combination of both on monoamines, growth, and corticosterone. Toxicology Reports, 1, 1046-1061.

Amos-Kroohs, R., Williams, M., Braun, A., Graham, D. L., Webb, C., Birtles, T., Greene, R., Vorhees, C., & Pisano, M. (2013). Neurobehavioral phenotype of C57BL/6J mice prenatally and neonatally exposed to cigarette smoke. Neurotoxicology and Teratalogy, 35, 34-45.

Graham, D. L., Erreger, K., Galli, A., & Stanwood, G. (2013). GLP-1 analog attenuates cocaine reward. Molecular Psychiatry, 18, 961-962.

Schaefer, T., Grace, C., Braun, A., Amos-Kroohs, R., Graham, D. L., Skelton, M., Williams, M., & Vorhees, C. (2013). Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA. International Journal of Neuropsychopharmacology, 11, 1-12.

Braun, A., Graham, D. L., Schaefer, T., Vorhees, C., & Williams, M. (2012). Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats. Neurobiology of Learning and Memory, 97, 402-408.

Graham, D. L., Amos-Kroohs, R., Braun, A., Grace, C., Schaefer, T., Skelton, M., Vorhees, C., & Williams, M. (2012). Neonatal (+)-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. International Journal of Neuropsychopharmacology, 6, 1-15.

Graham, D. L., Herring, N., Schaefer, T., Holland, K., Vorhees, C., & Williams, M. (2012). Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5- methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats. The Open Neuropsychopharmacology Journal, 5, 1-8.

Schaefer, T., Grace, C., Skelton, M., Graham, D. L., Gudelsky, G., Vorhees, C., & Williams, M. (2012). Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats. ACS Chemical Neuroscience, 3, 12-21.

Skelton, M., Graham, D. L., Schaefer, T., Grace, C., Braun, A., Burns, L., Williams, M., & Vorhees, C. (2012). Distinct periods of developmental sensitivity to the effects of 3,4-(±)- methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats. International Journal of Neuropsychopharmacology, 15, 811-824.

Vorhees, C., Graham, D. L., Braun, A., Richtand, N., & Williams, M. (2012). Prenatal immune challenge in rats: Altered responses to dopaminergic and glutamatergic agents in the absence of effects on cognition, anxiety, or acoustic startle. Synapse, 66, 725-737.

Graham, D. L., Grace, C., Braun, A., Schaefer, T., Skelton, M., Tang, P., Vorhees, C., & Williams, M. (2011). Effects of developmental stress and lead (Pb) on corticosterone after chronic and acute stress, brain monoamines, and blood Pb levels in rats. International Journal of Developmental Neuroscience, 29, 45-55.

Skelton, M., Schaefer, T., Graham, D. L., deGrauw, T., Clark, J., Williams, M., & Vorhees, C. (2011). Creatine transporter (CrT/ Slc6a8) knockout mice as a model of human CrT deficiency. PLoS One, 6.

Vorhees, C., He, E., Skelton, M., Graham, D. L., Schaefer, T., Grace, C., Braun, A., Amos-Kroohs, R., & Williams, M. (2011). Comparison of (+)-methamphetamine, ±- methylenedioxymethamphetamine (MDMA), (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze. Synapse, 65, 368-378.

Vorhees, C., Morford, L., Graham, D. L., Skelton, M., & Williams, M. (2011). Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug. Behavioral and Brain Functions, 7, 41-53.

Grace, C., Schaefer, T., Graham, D. L., Skelton, M., Williams, M., & Vorhees, C. (2010). Effects of inhibiting neonatal methamphetamine-induced corticosterone release in rats by adrenal autotransplantation on later learning, memory, and plasma corticosterone levels. International Journal of Developmental Neuroscience, 28, 331-342.

Grace, C., Schaefer, T., Herring, N., Graham, D. L., Skelton, M., Gudelsky, G., Williams, M., & Vorhees, C. (2010). Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicology and Teratalogy, 32, 346-355.

Graham, D. L., Herring, N., Schaefer, T., Vorhees, C., & Williams, M. (2010). Glucose and corticosterone changes in developing and adult rats following exposure to (±)-3,4- methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine. Neurotoxicology and Teratalogy, 32, 152-157.

Vorhees, C., Skelton, M., Grace, C., Schaefer, T., Graham, D. L., Braun, A., & Williams, M. (2009). Effects of (+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. International Journal of Developmental Neuroscience, 27, 289-298.

Graham, D. L., Noailles, P., & Cadet, J. (2008). Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges. Journal of Neurochemistry, 105, 1873-1885.

Refereed Book Chapters

Graham, D. L., Meyer, J., & Stanwood, G. (2018). Behavioral Phenotyping in Developmental Neurotoxicology – Simple Approaches using Unconditioned Behaviors in Rodents. In W. Slikker, M. Paule, & C. Wang (Eds.), Handbook of Developmental Neurotoxicity, Second Edition. Elsevier: New York. 

Graham, D. L., Schaefer, T., & Vorhees, C. (2011). Neurobehavioural Testing for Developmental Toxicity. In R.D. Hood (Ed.), Developmental and Reproductive Toxicology: A Practical Approach (pp. 346-387). CRC Press: Boca Raton, FL. 

Refereed Reports

Graham, D. L., Trammell, T., Anderson, L., Lee, G., Rubinstein, M., & Stanwood, G. (2016). Loss of dopamine D2 receptors in glutamatergic or GABAergic neurons produces differential behavioral outputs (Abstract). Society for Neuroscience Abstracts Vol 41, Program No. 832.05. 

Graham, D. L., Trammell, T., Anderson, L., & Stanwood, G. (2016). Behavioral consequences following deletion of the dopamine D2 receptor in forebrain GABAergic or glutamatergic neurons (Abstract). Neurotoxicol. Teratol 55. 

Graham, D. L., Durai, H., Garden, J., Cohen, E., Echevarria, F., & Stanwood, G. (2015). Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex (Abstract). Neurotoxicol. Teratol 49. 

Ross, E., Graham, D. L., & Stanwood, G. (2015). Developmental dopamine D2 receptor effects on interneuron development and behavior (Abstract). Neurotoxicol. Teratol 49. 

Graham, D. L., Durai, H., Galli, A., & Stanwood, G. (2014). Mapping glucagon-like peptide-1 receptor expression in the brain. Society for Neuroscience Abstracts Vol 39, Program No. 812.10. 

Graham, D. L., Buendia, M., Durai, H., Galli, A., & Stanwood, G. (2013). Glucagon-like peptide-1 receptor activation reduces cocaine reward (Abstract). Society for Neuroscience Abstracts Vol 38, Program No. 350.08. 

Graham, D. L., Cohen, E., Frederick, A., Echevarria, F., & Stanwood, G. (2012). Biochemical and behavioral alterations in the dopamine D2 receptor knockout mouse. Society for Neuroscience Abstracts Vol 37, Program No. 916.02. 

Graham, D. L., Amos-Kroohs, R., Braun, A., Grace, C., Schaefer, T., Skelton, M., Williams, M., & Vorhees, C. (2011). Long-term receptor alterations from developmental methamphetamine exposure in rats by use of selective pharmacological agonists and antagonists (Abstract). Neurotoxicol. Teratol 33 (4). 

Braun, A., Skelton, M., Burns, L., Graham, D. L., Schaefer, T., Amos-Kroohs, R., Vorhees, C., & Williams, M. (2010). Cognitive effects of chronic stress following acute (+)- methamphetamine treatment in adult rats (Abstract). Society for Neuroscience Abstracts Vol 36, Program No. 577.21. 

Graham, D. L., Amos-Kroohs, R., Braun, A., Grace, C., Schaefer, T., Skelton, M., Vorhees, C., & Williams, M. (2010). The developmental effects of lead, manganese, and chronic stress on rat behavior (Abstract). The Toxicologist Vol. 114 (1), Program No. 1600 (The Society of Toxicology's Annual Meeting Abstracts). 

Graham, D. L., Amos-Kroohs, R., Braun, A., Grace, C., Schaefer, T., Skelton, M., Vorhees, C., & Williams, M. (2010). The long-term behavioral effects of exposure to metals and chronic stress during development (Abstract). Neurobehavioral Teratology Society 34th Annual Meeting, Louisville, KY. Neurotoxicol. Teratol 32 (4). 

Graham, D. L., Vorhees, C., & Williams, T. (2010). The combination of developmental amphetamine-type stimulants and barren cage alters corticosterone and neurochemical levels in rats (Abstract). Society for Neuroscience Abstracts Vol 36, Program No. 367.3. 

Vorhees, C., Skelton, M., Graham, D. L., Schaefer, T., Grace, C., Braun, A., Amos-Kroohs, R., & Williams, M. (2010). Effects of overlapping ages of exposure to (+)-methamphetamine (MA) in rats on later allocentric and egocentric learning (Abstract). Neurotoxicol. Teratol 32 (4). 

Vorhees, C., Skelton, M., Graham, D. L., Schaefer, T., Grace, C., Braun, A., & Williams, M. (2010). Effects of age of exposure to 3,4-methylenedioxymethamphetamine (MDMA) in rats on later learning and behavior (Abstract). Neurotoxicol. Teratol 32 (4). 

Amos-Kroohs, R., Graham, D. L., Braun, A., Skelton, M., Schaefer, T., Grace, C., Vorhees, C., & Williams, M. (2009). Maternal isolation in rats but not Pb2+ alters HPA axis function and reduces immune system organ weights. Society for Neuroscience Abstracts Vol 35, Program No. 883.2. 

Braun, A., Scahefer, T., Grace, C., Graham, D. L., Skelton, M., Gudelsky, G., Vorhees, C., & Williams, M. (2009). Neonatal MDMA and/or citalopram exposure produces long-term deficits in path integration learning, but only MDMA affects spatial learning (Abstract). Neurotoxicol. Teratol 31(4. 

Braun, A., Skelton, M., Graham, D. L., Schaefer, T., Grace, C., Vorhees, C., & Williams, M. (2009). Gestational polyinosinic-polycytidylic acid induced maternal immune response in pregnant Sprague-Dawley rats produces sexually dimorphic changes and mild path integration deficits in offspring after 1 or 5 days of exposure (Abstract). Society for Neuroscience Abstracts Vol 35, Program No. 883.24. 

Graham, D. L., Vorhees, C., & Williams, M. (2009). Long-term alterations in dopamine and NMDA receptor function following methamphetamine exposure in the neonatal rat (Abstract). Society for Neuroscience Abstracts Vol 35, Program No. 842.22. 

Schaefer, T., Grace, C., Graham, D. L., Skelton, M., Gudelsky, G., Vorhees, C., & Williams, M. (2009). Neonatal MDMA and/or citalopram exposure produces long-term deficits in path integration learning, but only MDMA affects spatial learning (Abstract). Society for Neuroscience Abstracts Vol 35, Program No. 883.22. 

Skelton, M., Vorhees, C., Graham, D. L., Schaefer, T., Grace, C., Braun, A., & Williams, M. (2009). Examining criticial periods of neonatal 3,4-(±)-methylenedioxymethamphetamine (MDMA) administration on behavior (Abstract). Society for Neuroscience Abstracts Vol 35, Program No. 883.23. 

Vorhees, C., Skelton, M., Graham, D. L., Schaefer, T., Grace, C., Braun, A., & Williams, M. (2009). Search for the critical period in rats neonatally treated with 3,4-(±)- methylenedioxymethamphetamine: Effects on behavior. Neurotoxicol Teratol 31(4). 

Graham, D. L., Herring, N., Scahefer, T., Holland, K., Vorhees, C., & Williams, M. (2008). A comparison of seizure activity induced by (+)-methamphetamine, (±)-3,4- methylenedioxymethamphetamine, and 5-methoxydiisopropyltryptamine: an EEG study (Abstract). Society for Neuroscience Abstracts Vol 34, Program No. 60.11. 

Graham, D. L., Noailles, P., & Cadet, J. (2008). Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges (Abstract). Neurotoxicol. Teratol 30(3). 

Skelton, M., Grace, C., Schaefer, T., Graham, D. L., Vorhees, C., & Williams, M. (2008). Blockade of behavioral deficits induced by neonatal MDMA exposure in angiotensinogen-depleted transgenic rats (Abstract). Society for Neuroscience Abstracts Vol 34, Program No. 874.4. 

Graham, D. L., Noailles, P., & Cadet, J. (2007). Effects on dopamine (DA) and serotonin (5-HT) metabolism following an escalating dose-binge regimen of methamphetamine (Abstract). The Toxicologist Vol. 96 (1), Program No. 1050. 

Graham, D. L., Naoilles, P., Asanbe, O., Becker, K., Wood, W., Prabhu, V., & Cadet, J. (2006). Comparison of gene expression changes in the striatum, cortex and hippocampus of rats treated with an escalating dose-binge methamphetamine (METH) regimen (Abstract). The Toxicologist Vol. 90 (1), Program No. 2418. 

Graham, D. L., Naoilles, P., Ladenheim, B., & Cadet, J. (2006). Differential protection against methamphetamine (METH)-induced monoamine depletion following an escalating METH dose- binge regimen (Abstract). Society for Neuroscience Abstracts Vol 32, Program No. 293.3. 

Noailles, P., Graham, D. L., Hartman, J., Becker, K., Wood, W., Prabhu, V., & Cadet, J. (2006). The molecular consequences of in utero METH exposure on cortex of the rat neonate (Abstract). Society for Neuroscience Abstracts Vol 32, Program No. 621.14. 

Graham, D. L., McCoy, M., Pfeiffer, K., Noailles, P., & Cadet, J. (2005). Expression of glutamate receptor transcripts following an escalating dose regimen of methamphetamine (METH) (Abstract). Society for Neuroscience Abstracts Vol 31, Program No.1032.9. 

Graham, D. L., Noailles, P., Ladenheim, B., Moran, T., & Cadet, J. (2005). Neuroprotection against methamphetamine (METH) afforded by pretreatment with increasing doses of the drug is dependent on the dosing schedule of METH used during the drug challenge (Abstract). The Toxicologist Vol. 84 (1), Program No. 1544. 

Graham, D. L., Noailles, P., Ladenheim, B., Pfeiffer, K., Moran, T., Becker, K., Wood, W., Prabhu, V., & Cadet, J. (2005). Molecular and neurochemical consequences of in utero methamphetamine in rat cortex (Abstract). Society for Neuroscience Abstracts Vol 31, Program No.1026.13. 

McCoy, M., Graham, D. L., Noailles, P., Ladenheim, B., & Cadet, J. (2005). Methamphetamine- induced transcriptional responses in the rat striatum: evidence from microarray and PCR analyses (Abstract). Society for Neuroscience Abstracts Vol 31, Program No.1032.8. 

Graham, D. L., Naoilles, P., Becker, K., Wood, W., Ladenheim, B., Moran, T., & Cadet, J. (2004). Attenuation of methamphetamine (METH)-induced monoaminergic toxicity in rats with prior exposure to increasing METH doses (Abstract). Society for Neuroscience Abstracts Vol 30, Program No.917.3. 

Noailles, P., Lyles, J., Graham, D. L., Pfeiffer, K., Becker, K., Wood, W., Teichberg, D., & Cadet, J. (2004). Analysis of long-term molecular adaptations in the rat cortex resulting from in utero methamphetamine exposure: a microarray study (Abstract). Society for Neuroscience Abstracts Vol 30, Program No.917.1. 

Presentations

Invited Presentations at Conferences

Graham, D. L. (presented 2016). Drug reward, addiction, and the GLP-1R. Presentation at the meeting of FSU Neuroscience Undergraduate Student Association. (Local)

Graham, D. L. (presented 2015, May). Brains, guts, and glory: GLP-1R as the little receptor that could. Presentation at the meeting of FSU Program in Neuroscience. (Local)

Graham, D. L. (presented 2015, January). Exploiting brain-gut interactions in treating addiction – new roles for GLP-1 receptors in cocaine abuse. Presentation at Winter Conference on Brain Research, Winter Conference on Brain Research. (State)

Graham, D. L., Watt, E., Erreger, K., Galli, A., & Stanwood, G. (presented 2012). Activation of the glucagon-like peptide-1 receptor modulates dopamine neurotransmission and diminishes cocaine reward. Poster presentation at 2012 NIDA Mini-Convention: Frontiers in Addiction Research, NIDA, New Orleans, LA. (National)

Schaefer, T., Grace, C., Graham, D. L., Graham, D., Skelton, M., Vorhees, C., & Williams, M. (presented 2010). Neonatal MDMA and/or citalopram exposure in rats produces long term deficits in egocentric learning, but only MDMA affects allocentric learning. Poster presentation at 19th Annual meeting of the International Behavioral Neuroscience Society, Behavioral Neuroscience Society, Villisimius, Sardinia, Italy. (International)

Vorhees, C., He, E., Skelton, M., Graham, D. L., Schaefer, T., Grace, C., Braun, A., Amos-Kroohs, R., & Williams, M. (presented 2010). Comparison of amphetamines following binge dosing on multiple-T water maze learning. Presentation at 19th Annual meeting of the International Behavioral Neuroscience Society, Behavioral Neuroscience Society, Villisimius, Sardinia, Italy. (International)

Williams, M., Grace, C., Schaefer, T., Graham, D. L., Skelton, M., & Vorhees, C. (presented 2010). Inhibiting neonatal methamphetamine (MA)-induced corticosterone release in rats by adrenal autotransplantation: effects on later learning, memory, and plasma corticosterone levels. Poster presentation at 19th Annual meeting of the International Behavioral Neuroscience Society, Behavioral Neuroscience Society, Villisimius, Sardinia, Italy. (International)

Skelton, M., Vorhees, C., Graham, D. L., Schaefer, T., Grace, C., Braun, A., & Williams, M. (presented 2009). Examining critical periods of neonatal 3,4-(±)-methylenedioxymethamphetamine (MDMA) administration on behavior. Poster presentation at 18th Annual meeting of the International Behavioral Neuroscience Society, International Behavioral Neuroscience Society, Nassau, Bahamas. (International)

Graham, D. L., Grace, C., Scahefer, T., Skelton, M., Vorhees, C., & Williams, M. (presented 2008). Housing conditions but not Pb2+ during the neonatal period in rats interacts with an acute stressor on corticosterone release. Poster presentation at 17th Annual meeting of the International Behavioral Neuroscience Society, International Behavioral Neuroscience Society, St. Thomas, Virgin Islands. (International)

Graham, D. L. (presented 2006, April). Expression of glutamate transcripts following an escalating dose-binge methamphetamine regimen. Presentation at the meeting of Allegheny College, Biology Department and Neuroscience Program. (Local)

Graham, D. L. (presented 2004, October). Escalating doses of methamphetamine (METH) are protective against METH-induced monoamine depletion. Presentation at the meeting of DHHS/NIH/NIDA/IRP, Molecular Neuropsychiatry Branch. (State)

Graham, D. L., Noailles, P., McCoy, M., Teichberg, D., Wood, W., Becker, K., Frost, D., & Cadet, J. (presented 2004). Alterations in gene expression in perinatal mice following exposure to methamphetamine. Poster presentation at Experimental Biology (FASEB) Annual Meeting, FASEB, Washington, D.C. (National)

Noailles, P., Lyles, J., Graham, D. L., Pfeiffer, K., Becker, K., Wood, W., & Cadet, J. (presented 2004). Effects of in utero methamphetamine exposure on global gene expression in the rat pup CNS. Poster presentation at Experimental Biology (FASEB) Annual Meeting, FASEB, Washington, D.C. (National)

Invited Presentations at Symposia

Graham, D. (presented 2018, April). Developmental Consequences of Fetal Exposure to Opioids: Clinical Studies. In Justine Larson, Henrietta Bada (Chair), The developmental impact of opioid use in pregnancy, and pragmatic approaches to support children and families. Presentation at the meeting of SAMHSA, Rockville, MD. (National)

Invited Lectures and Readings of Original Work

Graham, D. (2017, November). Old drugs, new tricks: Exploiting brain-gut interactions in treating mental health disorders. Delivered at University of Evansville. (Local)

Contracts and Grants

Contracts and Grants Funded

Graham, D. L., & Stanwood, G. (Apr 2018–Mar 2020). Regulation of Mood by Dopamine D1 Receptors on Cerebral Cortical Interneurons. Funded by NIH / NIMH. (R21 MH116429). Total award $421,688. 

Graham, D. (Apr 2018–Mar 2020). One Drug, Several Uses: Pro-Cognitive and Antidepressant Effects of GLP-1 Receptor Agonists. Funded by NIH. (R03-MH110749-01A1). Total award $153,375. 

Graham, D. L. (May 2016–Nov 2017). GLP-1 Receptors as a Novel Therapeutic Target for Depression. Funded by FSU Council on Research & Creativity. Total award $13,000. 

Stanwood, Gregg (PI), & Graham, Devon Lee (Co-I). (May 2015–Aug 2015). GLP-1 Receptors and Psychostimulant Addiction. Funded by National Institute on Drug Abuse. (TBD). Total award $30,305. 

Graham, D., Stanwood, G., & Galli, A. (May 2014–Apr 2016). GLP-1 Receptors and Psychostimulant Addiction. Funded by NIH/NIDA. Total award $150,000. 

Graham, D. L. (Jan 2013–Jun 2014). The Glucagon-like Peptide-1 Receptor as a Therapeutic Target for Psychostimulant Addiction. Funded by Peter F. McManus Charitable Trust Grant. Total award $50,000. 

Stanwood, G., & Graham, D. L. (Jul 2010–Mar 2015). Dopaminergic Modulation of Brain Development. Funded by NIH/NIMH. Total award $0. 

Vorhees, C. V., & Graham, D. L. (trainee). (Oct 2007–Jun 2010). Training Grant in Teratology. Funded by NIH/NIEHS. Total award $0. 

Contracts and Grants Denied

Graham, D. L., & Stanwood, G. (Jul 2018). GLP-1 Receptor Impact the Development of Reward Circuitry and Dopamine Homeostasis. Submitted to NIH / NIDA. 

Graham, D. L. (Apr 2018). GLP-1 Receptors and Anxiety. Submitted to NIH/NIMH. 

Graham, D. L., & Stanwood, G. (Apr 2018). Forebrain Dopamine D2 Receptors Modulate Interneuron Development and Social Behavior. Submitted to NIH / NIMH. 

Published Abstracts

Graham, D. L., Trammell, T., Anderson, L., Lee, G., Rubinstein, M., & Stanwood, G. (2016). Loss of dopamine D2 receptors in glutamatergic or GABAergic neurons produces differential behavioral outputs. Society for Neuroscience Abstracts Vol 41, Program No. 832.05. 

Service

Florida State University

FSU University Service

Member, Animal Care and Use Committee (ACUC) (2018–present).

Asst. Director of Husbandry Operations, Laboratory Animal Resources Search Committee (2017).

FSU College Service

Member, College of Medicine Library and Learning Resources Committee (2015–present).

FSU Department Service

Member, Biomedical Sciences Research Faculty Evaluation Committee (2018–present).

Member, Biomedical Sciences By-Laws and Policy Committee (2015–2016).

The Profession

Editorial Board Membership(s)

Frontiers in Behavioral Neuroscience (2018–present).

Neurotoxicology and Teratology (2017–present).

Neurotoxicology and Teratology (2011–2016).

Guest Reviewer for Refereed Journals

Biological Psychiatry (2018–present).

International Journal of Clinical and Experimental Pathology (2018–present).

Journal of Trace Elements in Medicine and Biology (2018–present).

Translational Psychiatry (2018–present).

Frontiers in Behavioral Neuroscience (2017–present).

International Journal of Toxicology (2017–present).

Neurotoxicology and Teratology (2017–present).

Developmental Neuroscience (2007–present).

Service to Professional Associations

Executive Council, Developmental Neurotoxicology Society (2017–present).

Publications Committee (Elected), Developmental Neurotoxicology Society (DNTS), formerly Neurobehavioral Teratology Society (NBTS) (2016–present).

Web Committee (Chair), Developmental Neurotoxicology Society (DNTS), formerly Neurobehavioral Teratology Society (NBTS) (2013–present).

Membership Committee Appointee, Developmental Neurotoxicology Society (DNTS), formerly Neurobehavioral Teratology Society (NBTS) (2008–present).

Webmaster, Developmental Neurotoxicology Society (DNTS), formerly Neurobehavioral Teratology Society (NBTS) (2013–2018).

Membership Committee Appointee, Developmental Neurotoxicology Society (DNTS), formerly Neurobehavioral Teratology Society (NBTS) (2008–2011).

Student Advisory Committee (SAC) Representative, Society of Toxicology (2006–2007).

Student Advisory Committee, Liaison to the Committee on Diversity Initiatives (CDI), Society of Toxicology (2006–2007).

Student Head Representative, Society of Toxicology, National Capital Area Regional Chapter (NCAC) (2006–2007).

Undergraduate Education Program, Peer Mentor, Society of Toxicology (2007).

Student Head Representative, Society of Toxicology, National Capital Area Regional Chapter (NCAC) (2006–2007).

Toxicology Program Representative, University of Maryland Graduate Student Association (2004–2006).

Student Vice Representative, Society of Toxicology, National Capital Area Regional Chapter (NCAC) (2005–2006).

Vice President, University of Maryland Graduate Student Association (2005–2006).

Student Vice Representative, Society of Toxicology, National Capital Area Regional Chapter (NCAC) (2005–2006).

Faculty Judging Coordinator for Graduate Research Conference, University of Maryland Graduate Student Association (2005).

The Community

Assistant State Director, American Atheists (2019–present).

Additional Service Not Reported Elsewhere

Graham, D. (2018). Reviewer for poster and oral abstracts. 2018 Annual Biomedical Research Conference for Minority Students.